News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
The National Institute for Allergy and Infectious Diseases (NIAID) was awarded an Excellence in Technology Transfer award from the 2021 Federal Laboratory Consortium (FLC) awards. The FLC gave out 33 awards across nine different technology transfer categories, in addition to a COVID-19 Response
Are you interested in licensing a COVID-19 vaccine? As the pandemic continues, a safe, affordable, and efficacious vaccine continues to be of urgent importance. Scientists at NIAID have developed a vaccine against COVID-19 by utilizing the well-characterized vesicular stomatitis virus (VSV) encoding
Abraham Lincoln was the only president to have applied for a patent. His invention was never commercialized. As a young man, Lincoln took a flat boat load of merchandise down the Mississippi River from his then home in New Salem, Illinois, to New Orleans, Louisiana. At one point the boat slid onto a